Investigative Site

Manhasset, New York 11030

0 studies enrolling now · 2 studies all time

What they study most

Hereditary Hemochromatosis, Paroxysmal Nocturnal Hemoglobinuria (PNH)

Studies at this site

• Phase 2 Safety and Efficacy Study of Zilucoplan (RA101495) to Treat PNH Patients Who Have an Inadequate Response to Eculizumab — Completed
• A Study of LJPC-401 for the Treatment of Iron Overload in Adult Patients With Hereditary Hemochromatosis — Completed